Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis-Reference-Cited by-同舟云学术

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

Published:2021-07-31 Issue:12 Volume:77 Page:1815-1823
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Yang Mingwen,Ye Zekang,Mei Lianlian,Ullah Inam,Tan Chuchu,Wang Guoyu,Gu Qian,Lu Yi,Abdus Samee,Shi Lu,Gong Xiaoxuan,Bai Jianling,Eikelboom John W.,Li Chunjian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-021-03177-y.pdf

Reference24 articles.

1. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Munoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B (2019) 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 140(11):e596–e646. https://doi.org/10.1161/CIR.0000000000000678

2. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESCSD (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165. https://doi.org/10.1093/eurheartj/ehy394

3. Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ (2018) ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC Guideline Comparison. J Am Coll Cardiol 72 (23 Pt A): 2915–2931. https://doi.org/10.1016/j.jacc.2018.09.057

4. Binderup HG, Houlind K, Brasen CL, Madsen JS (2019) Identification of aspirin resistance using a PDW-miR92a-score: Validation in an intermittent claudication cohort. Clin Biochem 64:30–36. https://doi.org/10.1016/j.clinbiochem.2018.12.009

5. Schrör K (1997) Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 23(4):349–356. https://doi.org/10.1055/s-2007-996108

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of aspirin and indobufen in the treatment of coronary heart disease: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-08-15

2. The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention;Platelets;2024-06-19

3. Reversible and Non-Competitive Inhibition of Cyclooxygenase by Indobufen for Efficient Antiplatelet Action and Relief of Gastrointestinal Irritation;Pharmaceutics;2023-08-14

4. Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study;Frontiers in Pharmacology;2022-08-16